XML 44 R30.htm IDEA: XBRL DOCUMENT v3.22.1
Share-Based Compensation (Tables)
3 Months Ended
Mar. 31, 2022
Share-based Payment Arrangement [Abstract]  
Total Share-Based Compensation Expense
Total share-based compensation expense was as follows:
Three Months Ended
March 31,
20222021
(In thousands)
Stock option expense$3,440 $3,923 
Restricted stock expense4,778 6,227 
Performance restricted stock unit expense1,353 1,290 
Total pre-tax expense$9,571 $11,440 
Weighted Average Assumptions Used for Estimating Fair Values of Stock Options Granted The following weighted average assumptions were used in the Black-Scholes-Merton model to estimate the fair values of stock options granted during the periods indicated:
Three Months Ended
March 31, 2022
Year Ended December 31,
2021
Expected volatility24.5 %24.2 %
Expected term (years)5.05.0
Risk-free interest rate2.33 %0.85 %
Expected dividend yield0.65 %0.66 %
Black-Scholes-Merton fair value per stock option granted$32.54 $25.63 
Summary of Stock Option Activity and Related Information
The following is a summary of the Company’s stock option activity and related information:
SharesWeighted
Average
Exercise
Price
Weighted
Average
Remaining
Contractual
Life 
Aggregate
Intrinsic
Value
(In thousands)(Years)(In millions)
Outstanding at December 31, 20213,352 $76.08 
Granted608 134.69 
Exercised(142)62.75 
Forfeited(24)91.75 
Outstanding at March 31, 20223,794 $76.56 6.7$180.4 
Exercisable at March 31, 20222,361 $70.86 5.3$147.1 
Summary of Nonvested Restricted Stock Activity and Related Information
The following is a summary of the Company’s non-vested restricted stock activity and related information:
SharesWeighted
Average
 Grant Date
Fair Value
(In thousands)
Non-vested restricted stock outstanding at December 31, 2021413 $96.07 
Granted179 134.71 
Vested(107)86.05 
Forfeited(10)100.34 
Non-vested restricted stock outstanding at March 31, 2022475 $112.85 
The following is a summary of the Company’s non-vested performance restricted stock activity and related information:
SharesWeighted
Average
 Grant Date
Fair Value
(In thousands)
Non-vested performance restricted stock outstanding at December 31, 2021289 $85.29 
Granted87 134.69 
Performance assumption change 1
66 81.76 
Vested(161)81.76 
Forfeited(2)89.73 
Non-vested performance restricted stock outstanding at March 31, 2022279 $101.97 
_________________________________________
1 Reflects the number of PRSUs above target levels based on performance metrics.